On March 17 of 2024, the 15th China Industry-University-Research Collaboration Innovation Conference (hereinafter referred to as the CIUR Conference) was held in Beijing by the China Industry-University-Research Institute Collaboration Association with the theme of “Industry-University-Research Focus: New Dynamics, New Models, New Industries”. The CIUR Conference attracted representatives from across various sectors around the country, including government, industry, academia, research, and finance. This annual event serves as a platform for the Industry-University-Research (IUR) institute to summarize achievements, acknowledge contributions, and promote the in-depth integration of industries, universities, and research.
The China IUR Collaboration Innovation and Promotion Award is the highest award in the field of collaborative innovation across the country’s IUR institutes, which was approved by the Ministry of Science and Technology and the National Office of Science and Technology Awards in 2009. It comprises five awards, each with distinct characteristics: the IUR Collaboration Award for Outstanding Contribution, the IUR Collaboration Award for Innovation, the IUR Collaboration Award for Promotion, the IUR Collaboration Award for Innovation Achievement, and the IUR Award for Craftsmanship Spirit.
Professor HUANG Ailong has long been involved in research on the pathogenesis and comprehensive prevention and control of infectious diseases. He has made remarkable contributions to the field of Hepatitis B virus (HBV) replication regulation, drug resistance mechanisms, antiviral drug screening, and the pathogenesis of liver diseases associated with HBV. He has proposed a therapeutic strategy via the epigenetic regulation of HBV covalently closed circular DNA (cccDNA). During the COVID-19 pandemic, Prof. Huang responded actively to the significant demands of the country in dealing with the pandemic. He contributed to the development of diagnostic reagents for COVID-19 and conducted research on clinical and immunological characteristics. Prof. Huang led his team in developing COVID-19 antigen/antibody test kits (with 5 national Class III medical device certificates) and a prophylactic COVID-19 neutralizing antibody nasal spray.
This award is a recognition of Prof. Huang’s continuous efforts in promoting the transformation and implementation of IUR collaboration in major infectious diseases and developing the system engineering for IUR construction. It is also a great encouragement for CQMU to further innovate the IUR mechanism and establish an ecosystem for medical transformation in the future.
